List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 450 studies with search of: "Tacrolimus"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Sirolimus/Tacrolimus Versus Tacrolimus/Methotrexate for Preventing Graft-Versus-Host Disease (GVHD)
Conditions: Leukemia, Myelocytic, Acute;   Leukemia, Lymphocytic, Acute;   Leukemia, Myeloid, Chronic;   Myelodysplastic Syndromes
Interventions: Drug: Tacrolimus/methotrexate;   Drug: Tacrolimus/sirolimus
2 Active, not recruiting Comparative Study of Modified Release (MR) Tacrolimus/MMF in de Novo Kidney Transplant Recipients
Condition: Kidney Transplantation
Interventions: Drug: Tacrolimus Modified Release (MR);   Drug: Tacrolimus;   Drug: cyclosporine microemulsion;   Drug: mycophenolate mofetil
3 Completed Pharmacokinetic Drug Interaction Between Ezetimibe and Tacrolimus After Single Dose Administration in Healthy Subjects
Conditions: Pharmacokinetics;   Drug Interactions;   Hypercholesterolemia;   Immunosuppression
Interventions: Drug: 1 tablet Ezetrol(R) (ezetimibe), MSD Sharp & Dohme GmbH, Germany;   Drug: 1 capsule Prograf(R) (tacrolimus), Astellas Pharma GmbH, Germany;   Drug: 1 tablet Ezetrol(R) + 1 capsules Prograf(R)
4 Completed A Study to Evaluate and Compare the Efficacy and Safety of FK506MR vs Prograf® in Stable Liver Transplantation Patients
Condition: Liver Transplantation
Interventions: Drug: Prograf;   Drug: FK506MR capsule
5 Recruiting Safety and Efficacy of LCP-Tacro™ Once Daily in Stable Renal Transplant Patients Converted From Prograf® Twice Daily
Condition: Acute Allograft Rejection
Interventions: Drug: LCP-Tacro™ Tablets (tacrolimus);   Drug: Prograf® capsules (tacrolimus)
6 Completed A Study to Compare the Efficacy and Safety of FK506MR vs Prograf® in Patients Undergoing Liver Transplantation
Condition: Liver Transplantation
Interventions: Drug: Tacrolimus modified-release;   Drug: Prograf
7 Recruiting Efficacy and Safety of Concentration-Controlled Everolimus to Eliminate or to Reduce Tacrolimus Compared to Tacrolimus in de Novo Liver Transplant Recipients
Condition: Liver Transplantation
Interventions: Drug: Everolimus;   Drug: Tacrolimus;   Drug: Tacrolimus
8 Completed A Study of a Modified-Release Tacrolimus Based Immunosuppression Regimen in Stable Pediatric Liver Transplant Patients
Condition: Liver Transplantation
Interventions: Drug: tacrolimus modified release (MR);   Drug: tacrolimus
9 Completed A Study to Assess the Pharmacokinetics of a Modified-Release Tacrolimus Based Immunosuppression Regimen in Stable Kidney Transplant Patients
Condition: Kidney Transplantation
Interventions: Drug: Tacrolimus Modified Release (MR);   Drug: tacrolimus
10 Completed A Study to Assess the Pharmacokinetics of a Modified-Release Tacrolimus Based Immunosuppression Regimen in Stable Liver Transplant Patients
Condition: Liver Transplantation
Interventions: Drug: tacrolimus modified release (MR);   Drug: tacrolimus
11 Completed A Study to Compare the Efficacy and Safety of FK506MR vs Prograf® in Patients Undergoing Kidney Transplantation
Condition: Kidney Transplantation
Interventions: Drug: FK506MR;   Drug: Prograf;   Drug: Mycophenolate Mofetil;   Drug: Methylprednisolone;   Drug: Prednisolone
12 Recruiting A Randomized Study to Assess the Safety and Efficacy of Prograf vs Prograf-XL in de Novo Kidney Transplant Recipients
Conditions: Kidney Transplantation;   Transplantation Immunology;   Host vs Graft Reaction
Interventions: Drug: Prograf-XL;   Drug: Prograf;   Drug: MMF
13 Recruiting A Randomized Study to Assess the Safety and Efficacy of Prograf vs Prograf-XL in de Novo Liver Transplant Recipients.
Conditions: Liver Transplantation;   Transplantation Immunology;   Host vs Graft Reaction
Interventions: Drug: Prograf-XL;   Drug: Prograf;   Drug: MMF
14 Recruiting PRIDE - Prograf Investigation of Diet and Exercise. A Pilot Trial of the Effect of Dietary and Exercise Intervention in Patients Who Have Received a Renal Transplant on Tacrolimus (Prograf®)
Conditions: Renal Transplantation;   Transplantation, Renal;   Grafting, Kidney;   Transplantation, Kidney
Intervention: Drug: FK506 Prograf (tacrolimus) with diet and exercise intervention.
15 Completed Tacrolimus and Daclizumab Versus Tacrolimus and Steroids in Liver Recipients Receiving Sub-Optimal Grafts
Condition: Liver Transplantation
Intervention: Drug: TACROLIMUS
16 Completed Tacrolimus (FK506) Study in Moderate to Severe Refractory Ulcerative Colitis Patients
Condition: Ulcerative Colitis
Interventions: Drug: tacrolimus;   Drug: Placebo
17 Completed Sequential Therapy (FK506 + Monoclonal Anti-IL2R Antibodies + MMF) Versus FK506 With Steroids in Liver TX
Condition: Liver Transplantation
Interventions: Drug: tacrolimus;   Drug: Anti-IL2R AB;   Drug: Mycophenolate mofetil;   Drug: prednisone
18 Enrolling by invitation Pharmacokinetics of Sublingual Versus Oral Tacrolimus in Patients Awaiting Kidney Transplantation
Condition: Kidney Failure, Chronic
Interventions: Drug: Tacrolimus/Clotrimazole Troche;   Drug: Tacrolimus/Nystatin Suspension
19 Completed A Study to Assess the Safety and Efficacy of Prograf and MR4 in Kidney Transplantation Patients
Condition: Kidney Transplantation
Interventions: Drug: Prograf;   Drug: MR4
20 Recruiting Tacrolimus Treatment of Patients With Idiopathic Membranous Nephropathy
Condition: Idiopathic Membranous Nephropathy
Intervention: Drug: Tacrolimus

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services